In analysis by infection, presence of each of the 37 type-specific HPV infections was evaluated for each individual at each visit (point prevalence) or in any of the samples collected over the course of the study (cumulative prevalence).
In analysis by individual, a subject was considered infected if one or more of the 37 HPV types evaluated were detected at each visit (point prevalence) or detected in any of the samples collected over the course of the study (cumulative prevalence).
Table 2 shows that, at each wave, the prevalence of current smoking for MZ twins was lower than for DZ twins.
We also investigated the influence of education on prevalence at each age range and compared our observed prevalence rates with those from the 2001 National Health Survey (NHS) to see if existing data could be used to augment national estimates.
For example, in Caucasians it occurred in 35.5%, 32.6% and 31.4% at baseline, year 1 and year 2, respectively, while in patients of African ancestry the prevalence of MetS prevalence at each visit was 57%, 38.8% and 62% and in Koreans it was 41.7%29.2%% and 32.8%, respectively.
In this paper we looked at equal prevalence from each class, and at the case of 2/3 to 1/3 prevalence split in our simulations.
At each sampling moment, prevalences of positive individuals were calculated.
At each evaluation, the prevalences of most indicators of neuropathy were higher in the secondary intervention cohort than in the primary prevention cohort.
To quantify the uncertainties surrounding the model predictions, we plotted the probability of each prediction location having a prevalence >50%, rather than mean predicted prevalence at each location.
The probabilities were calculated from the posterior distributions of predicted prevalence at each location (i.e., if 95% of the posterior distribution of predicted prevalence was >0.5, the probability of prevalence >50% at that location was 95%).
